| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.34 | 5e-09 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.3 | 4e-08 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.27 | 7e-07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.27 | 3e-06 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.28 | 5e-06 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.24 | 0.0001 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.23 | 0.0002 |